WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced the appointment of Gail Cawkwell, MD, PhD, as Chief Medical Officer, effective June 27, 2022.
“We are excited to welcome Dr. Cawkwell to Aclaris at this time as we are executing on a number of clinical programs,” said Dr. Neal Walker, President and CEO of Aclaris. “Her leadership experience in pharmaceutical development, as well as her clinical background, will be extremely valuable in navigating the strategic direction of our drug development pipeline.”
Dr. Cawkwell is a pediatric rheumatologist and epidemiologist who brings over 20 years of pharmaceutical development and medical affairs experience in large and small companies, and across multiple disease areas. Most recently, she served as Senior Vice President, Medical Affairs, Safety & Pharmacovigilance at Intercept Pharmaceuticals, Inc. Prior to that, Dr. Cawkwell worked for Purdue Pharma L.P. most recently as Special Advisor to the Board of Directors, and Pfizer Inc., most recently as Vice President Medicine Team Lead for Pfizer’s tofacitinib franchise. Dr. Cawkwell also previously served as a Clinical Instructor of Pediatrics at Columbia Presbyterian Health Center.
“As a rheumatologist, I am thrilled to join Aclaris, a company passionate about finding treatment options for patients with immuno-inflammatory conditions,” said Dr. Cawkwell. “I look forward to helping Aclaris advance its clinical pipeline and delivering on its clinical development goals.”
Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.